HealthSnap's $25M Series B Backed Care-at-Home Infrastructure

HealthSnap closed a $25M Series B on February 21, 2024, led by Sands Capital with participation from new and returning investors. The Miami healthcare technology company said the financing brought its total funding to $48.5M and would support a larger national clinical team, faster product development, broader care-at-home access, and an AI-powered population health and analytics initiative.

The round landed at a practical fault line in American healthcare. Chronic conditions are managed across months and years, but the traditional care model still concentrates attention inside episodic office visits. HealthSnap is building the connective tissue between those moments by combining remote monitoring, chronic care management, connected devices, care navigation, EHR integrations, and operational workflows in one platform.

That makes the Series B more than a vote for virtual care as a category. It is a wager that the durable businesses in remote healthcare will be the ones that help providers turn continuous patient data into clinical action without asking health systems to assemble every technical, staffing, logistics, and reimbursement component themselves.

What Happened

The $25M Series B announcement named Sands Capital as lead investor. Comcast Ventures, Acronym Venture Capital, and Florida Opportunity Fund joined as new investors, while Asclepius Growth Capital, Florida Funders, MacDonald Ventures, and TGH Ventures also participated. Scott Frederick, identified in the announcement as a Managing Partner at Sands Capital, joined HealthSnap's board.

HealthSnap did not disclose a valuation or ownership terms. The company said the transaction lifted cumulative funding to $48.5M.

The Company Behind the Round

HealthSnap was founded in Miami in 2015 by Samson Magid, Chase Preston, and Wesley Smith. The company's current leadership page lists Magid as CEO, Preston as COO, Smith as Chief Science Officer, and Jared von Halle as CTO. That mix reflects the operating reality of virtual care: clinical design, software infrastructure, and service delivery have to move together.

The platform supports Remote Patient Monitoring and Chronic Care Management, often shortened to RPM and CCM. HealthSnap connects patients and care teams through cellular-enabled devices, care coordination, population analytics, billing workflows, and EHR integrations, allowing provider organizations to extend chronic-condition management into the home.

Traction Before the Financing

At the time of the round, HealthSnap reported more than 150 provider organizations and health systems on its platform and over 300% growth in patient programs during the prior year. Samson Magid said the business grew more than 500% in 2023 in a Refresh Miami interview, while the company highlighted partnership expansions with UnityPoint Health and Prisma Health.

HealthSnap also said its platform supported more than 100 chronic conditions and integrated with more than 80 EHRs. Those numbers were company-provided rather than independently audited, but they explain the investment logic: HealthSnap was presenting evidence that its product could function across many clinical workflows instead of remaining a narrow pilot tool.

Why This Funding Mattered

Remote monitoring sounds simple when reduced to a device and a dashboard. In practice, providers also need patient enrollment, device logistics, data integration, care-team workflows, reimbursement support, escalation protocols, and evidence that the program improves outcomes. Each missing layer becomes another reason a promising initiative stalls after the pilot.

HealthSnap's pitch was that an integrated model could absorb much of that complexity. Comcast Ventures framed its investment around the combination of connectivity, connected devices, a virtual care platform, and clinical services. That is a more demanding business than selling software alone, but it can also become more embedded in a provider's daily operations.

Where the Capital Was Going

HealthSnap said the financing would help assemble its national clinical team, accelerate the product roadmap, expand access to care in the home, and begin building an AI-powered population health and analytics solution. The plans were forward-looking at the time of the announcement, so they should be read as intended uses of capital rather than completed outcomes.

The analytics effort was strategically important because remote care creates a growing stream of longitudinal information between visits. The opportunity is not merely to collect more readings. It is to help clinical teams identify risk, prioritize attention, and make the data useful inside existing care and reimbursement workflows without turning every alert into more noise.

What the Round Signaled

The HealthSnap Series B showed investor interest in the operating layer beneath care at home. Provider organizations do not only need another patient-facing application. They need infrastructure that can connect devices, people, clinical decisions, and payment mechanics across a fragmented healthcare environment.

That is the real test for remote patient monitoring companies. Data collection is becoming easier, but durable value depends on whether a platform can convert that information into timely interventions, sustainable provider economics, and a patient experience people can actually use. HealthSnap's $25M round backed the argument that integration, not novelty, would decide which virtual-care platforms become part of healthcare's permanent machinery.